logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Imaging In Cns Drug Discovery And Development Implications For Disease Therapy 1st Edition David Borsook

  • SKU: BELL-4391252
Imaging In Cns Drug Discovery And Development Implications For Disease Therapy 1st Edition David Borsook
$ 31.00 $ 45.00 (-31%)

4.8

34 reviews

Imaging In Cns Drug Discovery And Development Implications For Disease Therapy 1st Edition David Borsook instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 6.31 MB
Pages: 396
Author: David Borsook, Edward Bullmore, Lino Becerra, Richard Hargreaves (auth.), David Borsook, Lino R. Beccera, Edward Bullmore, Richard J. Hargreaves (eds.)
ISBN: 9781441901330, 9781441901347, 1441901337, 1441901345
Language: English
Year: 2009
Edition: 1

Product desciption

Imaging In Cns Drug Discovery And Development Implications For Disease Therapy 1st Edition David Borsook by David Borsook, Edward Bullmore, Lino Becerra, Richard Hargreaves (auth.), David Borsook, Lino R. Beccera, Edward Bullmore, Richard J. Hargreaves (eds.) 9781441901330, 9781441901347, 1441901337, 1441901345 instant download after payment.

Imaging is a key area of translational research that provides a unique bridge from the laboratory to the clinic as the same techniques and technologies can applied across the various phases of drug development. Neuroimaging is now central to research and drug development in the neurosciences since it can be used to detect the pharmacological and physiological consequences of drug action within the living brain. Today neuroimaging is used primarily as a biomarker to help optimize our decision-making processes. Neuroimaging tools and technologies can be used to select drug candidates, confirm they engage their targets, link occupancy to biology and then, in a translational fashion, be used to help design the best clinical studies that truly test therapeutic hypotheses.

Topics covered include:

  • The role of imaging in drug development
  • Imaging approaches including structural, functional, molecular and chemical imaging
  • Imaging drug action including neuroreceptor mapping to examine drug occupancy characteristics, the involvement of specific neurotransmitter systems in CNS diseases and mechanisms of action
  • Functional mapping to provide pharmacodynamic evidence of central activity, "CNS fingerprinting" of the neuroanatomy of drug effects and disease drug interactions
  • Imaging disease states in preclinical and clinical domains

Neuroimaging today is all about the need to identify the best molecules, doses and hypotheses to advance into later stage long term extensive clinical trials that can often be confounded by high placebo response rates. Better decision making in early development allows resources to be focused on the drug candidates and therapeutic hypotheses that have the highest probability of success so that we can bring medical advances to patients as quickly as possible. Imaging in CNS Drug Discovery and Development was written by a group of preeminent international experts in the field of imaging.

Related Products